Valuation check: 4547.T's profit margin is 14.16%, above the sector sector average of 13.23%.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
The latest profit margin for 4547.T is 14.16% as of June 2026. That compares with 13.85% in the prior-year period — up 2.3% year over year. That is above the sector sector average of 13.23%. Investors often review this figure alongside Kissei Pharmaceutical , Ltd.'s historical trend and sector peers before judging valuation or financial health.
Over the past year, 4547.T's profit margin moved from 13.85% to 14.16% — a 2.3% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Kissei Pharmaceutical , Ltd.'s valuation or profitability profile.
Against its sector companies, 4547.T currently prints 14.16% for profit margin, while the sector average sits near 13.23%. That is roughly 7.1% above the sector mean. Large gaps often invite a closer look at Kissei Pharmaceutical , Ltd.'s growth, margins, and balance sheet.
Profit Margin shows how effectively Kissei Pharmaceutical , Ltd. converts resources into returns. At 14.16%, 4547.T may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 13.85% in the prior-year period — up 2.3% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting 4547.T's profit margin (14.16%), review year-over-year change from 13.85%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.